Fundraising Fox
Vaxcell Bio
3 known investors
Find your way into Vaxcell Bio
Sign up to see every warm intro you have to Vaxcell Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Vaxcell Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
VaxcellBio develops anti-cancer immunotherapies, including NK cell therapies, CAR cell therapies, targeted anti-cancer agents, and antibody treatments for cancers such as liver, small-cell lung, pancreatic, solid, and blood cancers. It also develops immuno-oncology products for companion animals, including treatments for mammary tumors and lymphoma.
Investors · 3
Frequently asked questions
- What does Vaxcell Bio do?
- VaxcellBio develops anti-cancer immunotherapies, including NK cell therapies, CAR cell therapies, targeted anti-cancer agents, and antibody treatments for cancers such as liver, small-cell lung, pancreatic, solid, and blood cancers. It also develops immuno-oncology products for companion animals, including treatments for mammary tumors and lymphoma.
- Who are Vaxcell Bio's investors?
- Vaxcell Bio's investors include Aju IB Investment, DAYLI Partners, LB Investment.